News About: Pharm. Industry
Zuellig Pharma to focus on distribution of vaccines
Zuellig Pharma, a regional distributor of pharmaceutical and health care products, said Tuesday that it will concentrate on distributing more high-priced drugs, such as vaccines and antibiotics, in the domestic logist...
Plavix combination drug market emerging as blue chip
Many major Korea pharmaceutical manufacturers are poised to introduce a combination product of Plavix and Aspirin (clopidogrel + acetylsalicylate 75 mg) with the hope of acquiring large share of the blockbuster drug a...
FTC to get tough on rebate
The Fair Trade Commission said it will look into any illegal rebate practices based on a revised version of fair trade rules on drugs, which take effect from December 20.
The rules are aimed at to ban the provision...
Pharmaceutical companies to shun direct transaction with pharmacy
Influenced by the government’s anti-rebate policy, a number of pharmaceutical firms are moving forward to hospital markets, while shunning away from pharmacy market.
What has turned pharmaceutical companies around?...
Lilly Korea set sales target of Cialis 5 mg at 10 billion won
Lilly Korea, the U.S. based multination drugmaker’s Korean branch, said it has set its sales target of Cialis 5 mg at 100 billion next year, according to the company Friday.
Lilly Korea said that it held a year-end...
Wholesalers on alert over drug bidding of Samsung Medical Center
A friction between drug wholesalers and a pharmaceutical firm has been on the surface over the drug bidding of Samsung Medical Center due tomorrow.
In the process of reviewing the estimated drug prices, the drugmak...
Pharmaceutical firms to speed up M&A
The local pharmaceutical industry will undergo a major transformation next year as tightening regulations and uphill competition lingers on, according to industry analysts.
Korean pharmaceutical companies will spee...
Pharmaceutical firms advised to go global
Korean pharmaceutical companies, which traditionally have depended on the local market, should turn their eyes on the overseas market next year, an industry expert said.
“The Korean pharmaceutical makers are in a s...
MSD Korea fined 50 million won for illegal ads
The Korea Food and Drug Administration said Wednesday that it has fined 50 million won on MSD Korea for illegal advertisements of Singulair tablets, prescription drug, towards the general public in hospitals using a p...
Keunwha Pharm order to suspend drug manufacturing business
The government punished Keunwha Pharmaceutical Co. for illegal rebate activities on Thursday.
The Korea Food and Drug Administration ordered Keunwha Pharm to stop the manufacture of some drugs for three months.
...
